True Diagnostics, Inc. Receives FDA 510(k) Clearance to Market VeriClear(TM) Digital Test Device for Early Result Pregnancy

SAN DIEGO, May 28, 2019 -- (Healthcare Sales & Marketing Network) -- True Diagnostics, Inc. (True), a leading company for Point of Care Answers, announced today that its VeriClear™ Digital Early Result Pregnancy Test has received 510(k) marketing clearanc... Diagnostics, FDA True Diagnostics, VeriClear, Pregnancy Test, chorionic gonadotropin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news